Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.04
AMSG's Cash to Debt is ranked lower than
87% of the 238 Companies
in the Global Medical Care industry.

( Industry Median: 0.33 vs. AMSG: 0.04 )
Ranked among companies with meaningful Cash to Debt only.
AMSG' s Cash to Debt Range Over the Past 10 Years
Min: 0.04  Med: 0.13 Max: 1.51
Current: 0.04
0.04
1.51
Equity to Asset 0.36
AMSG's Equity to Asset is ranked lower than
65% of the 230 Companies
in the Global Medical Care industry.

( Industry Median: 0.46 vs. AMSG: 0.36 )
Ranked among companies with meaningful Equity to Asset only.
AMSG' s Equity to Asset Range Over the Past 10 Years
Min: 0.31  Med: 0.53 Max: 0.8
Current: 0.36
0.31
0.8
Interest Coverage 10.47
AMSG's Interest Coverage is ranked higher than
61% of the 187 Companies
in the Global Medical Care industry.

( Industry Median: 6.17 vs. AMSG: 10.47 )
Ranked among companies with meaningful Interest Coverage only.
AMSG' s Interest Coverage Range Over the Past 10 Years
Min: 4.74  Med: 16.88 Max: 28.93
Current: 10.47
4.74
28.93
F-Score: 6
Z-Score: 1.48
M-Score: -2.27
WACC vs ROIC
4.03%
11.86%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 23.54
AMSG's Operating margin (%) is ranked higher than
93% of the 233 Companies
in the Global Medical Care industry.

( Industry Median: 7.18 vs. AMSG: 23.54 )
Ranked among companies with meaningful Operating margin (%) only.
AMSG' s Operating margin (%) Range Over the Past 10 Years
Min: 24.06  Med: 31.80 Max: 35.12
Current: 23.54
24.06
35.12
Net-margin (%) 6.35
AMSG's Net-margin (%) is ranked higher than
59% of the 236 Companies
in the Global Medical Care industry.

( Industry Median: 4.49 vs. AMSG: 6.35 )
Ranked among companies with meaningful Net-margin (%) only.
AMSG' s Net-margin (%) Range Over the Past 10 Years
Min: 3.31  Med: 6.88 Max: 8.32
Current: 6.35
3.31
8.32
ROE (%) 8.32
AMSG's ROE (%) is ranked lower than
55% of the 213 Companies
in the Global Medical Care industry.

( Industry Median: 9.52 vs. AMSG: 8.32 )
Ranked among companies with meaningful ROE (%) only.
AMSG' s ROE (%) Range Over the Past 10 Years
Min: 4.03  Med: 9.79 Max: 11.84
Current: 8.32
4.03
11.84
ROA (%) 2.87
AMSG's ROA (%) is ranked lower than
56% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 3.79 vs. AMSG: 2.87 )
Ranked among companies with meaningful ROA (%) only.
AMSG' s ROA (%) Range Over the Past 10 Years
Min: 1.4  Med: 4.06 Max: 6.75
Current: 2.87
1.4
6.75
ROC (Joel Greenblatt) (%) 238.26
AMSG's ROC (Joel Greenblatt) (%) is ranked higher than
94% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 17.56 vs. AMSG: 238.26 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
AMSG' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 53.23  Med: 124.09 Max: 236.73
Current: 238.26
53.23
236.73
Revenue Growth (3Y)(%) 19.20
AMSG's Revenue Growth (3Y)(%) is ranked higher than
85% of the 173 Companies
in the Global Medical Care industry.

( Industry Median: 7.40 vs. AMSG: 19.20 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
AMSG' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 10.3  Med: 15.80 Max: 20.9
Current: 19.2
10.3
20.9
EBITDA Growth (3Y)(%) 12.00
AMSG's EBITDA Growth (3Y)(%) is ranked higher than
67% of the 141 Companies
in the Global Medical Care industry.

( Industry Median: 6.60 vs. AMSG: 12.00 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
AMSG' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -6.8  Med: 11.90 Max: 40.6
Current: 12
-6.8
40.6
EPS Growth (3Y)(%) 17.10
AMSG's EPS Growth (3Y)(%) is ranked higher than
72% of the 128 Companies
in the Global Medical Care industry.

( Industry Median: 5.90 vs. AMSG: 17.10 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
AMSG' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -7.9  Med: 10.30 Max: 131.3
Current: 17.1
-7.9
131.3
» AMSG's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-08-04)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q2 2015

AMSG Guru Trades in Q2 2015

Joel Greenblatt 14,914 sh (+40.47%)
Jim Simons Sold Out
» More
Q3 2015

AMSG Guru Trades in Q3 2015

Paul Tudor Jones 5,324 sh (New)
Steven Cohen 43,600 sh (New)
Jim Simons 3,769 sh (New)
Joel Greenblatt 156,158 sh (+947.06%)
» More
Q4 2015

AMSG Guru Trades in Q4 2015

Vanguard Health Care Fund 376,000 sh (New)
Jim Simons 174,269 sh (+4523.75%)
Joel Greenblatt 494,371 sh (+216.58%)
Paul Tudor Jones 13,284 sh (+149.51%)
Steven Cohen 11,500 sh (-73.62%)
» More
Q1 2016

AMSG Guru Trades in Q1 2016

Mario Gabelli 5,027 sh (New)
Steven Cohen 76,000 sh (+560.87%)
Vanguard Health Care Fund 376,000 sh (unchged)
Jim Simons 125,269 sh (-28.12%)
Paul Tudor Jones 8,900 sh (-33.00%)
Joel Greenblatt 74,610 sh (-84.91%)
» More
» Details

Insider Trades

Latest Guru Trades with AMSG

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Preferred stocks of Amsurg Corp

SymbolPriceYieldDescription
AMSGP141.403.71

Business Description

Industry: Health Care Providers » Medical Care
Compare:LSE:MDC, ASX:SHL, NYSE:MD, FRA:CLS1, NAS:WOOF, NAS:ACHC » details
Traded in other countries:AJH.Germany,
Amsurg Corp owns and operates ambulatory surgery centers. The Company acquire, develops and operates ASCs through the formation of partnership with physicians to serve the communities in its markets.

AmSurg Corp was formed in 1992. The Company owns and operates short stay ambulatory surgery centers or "ASC"s in the United States. The Company acquires, develops and operates ASCs through the formation of strategic partnerships with physicians to serve the communities in its markets. The Company has developed its operating model to encourage physicians to affiliate with them. It operates 242 surgery centers in 34 states and the District of Columbia. As of December 31, 2013, 151 of its centers performed gastrointestinal endoscopy procedures, 48 centers were multi-specialty centers, 36 centers performed ophthalmology surgery procedures and seven centers performed orthopaedic procedures. The Company market its surgery centers directly to patients, referring physicians and third party payors, including health maintenance organizations, or "HMO"s, preferred provider organizations, or "PPO"s, other managed care organizations, and employers. The Company competes with hospitals and other surgery centers in recruiting physicians to utilize its surgery centers, for patients and for the opportunity to contract with payors. The healthcare industry is subject to extensive regulation by a number of governmental entities at the federal, state and local level.

Ratios

vs
industry
vs
history
P/E(ttm) 24.69
AMSG's P/E(ttm) is ranked higher than
56% of the 183 Companies
in the Global Medical Care industry.

( Industry Median: 26.08 vs. AMSG: 24.69 )
Ranked among companies with meaningful P/E(ttm) only.
AMSG' s P/E(ttm) Range Over the Past 10 Years
Min: 9.07  Med: 17.84 Max: 64.73
Current: 24.69
9.07
64.73
Forward P/E 15.38
AMSG's Forward P/E is ranked higher than
65% of the 75 Companies
in the Global Medical Care industry.

( Industry Median: 16.64 vs. AMSG: 15.38 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 24.61
AMSG's PE(NRI) is ranked higher than
56% of the 179 Companies
in the Global Medical Care industry.

( Industry Median: 25.40 vs. AMSG: 24.61 )
Ranked among companies with meaningful PE(NRI) only.
AMSG' s PE(NRI) Range Over the Past 10 Years
Min: 8.55  Med: 18.31 Max: 63.28
Current: 24.61
8.55
63.28
P/B 1.90
AMSG's P/B is ranked higher than
66% of the 217 Companies
in the Global Medical Care industry.

( Industry Median: 2.55 vs. AMSG: 1.90 )
Ranked among companies with meaningful P/B only.
AMSG' s P/B Range Over the Past 10 Years
Min: 0.93  Med: 1.75 Max: 3.06
Current: 1.9
0.93
3.06
P/S 1.41
AMSG's P/S is ranked higher than
54% of the 233 Companies
in the Global Medical Care industry.

( Industry Median: 1.55 vs. AMSG: 1.41 )
Ranked among companies with meaningful P/S only.
AMSG' s P/S Range Over the Past 10 Years
Min: 0.7  Med: 1.32 Max: 2.41
Current: 1.41
0.7
2.41
PFCF 8.26
AMSG's PFCF is ranked higher than
87% of the 112 Companies
in the Global Medical Care industry.

( Industry Median: 20.97 vs. AMSG: 8.26 )
Ranked among companies with meaningful PFCF only.
AMSG' s PFCF Range Over the Past 10 Years
Min: 1.92  Med: 4.89 Max: 44.58
Current: 8.26
1.92
44.58
POCF 7.29
AMSG's POCF is ranked higher than
76% of the 153 Companies
in the Global Medical Care industry.

( Industry Median: 13.59 vs. AMSG: 7.29 )
Ranked among companies with meaningful POCF only.
AMSG' s POCF Range Over the Past 10 Years
Min: 1.75  Med: 4.42 Max: 14.37
Current: 7.29
1.75
14.37
EV-to-EBIT 10.94
AMSG's EV-to-EBIT is ranked higher than
87% of the 179 Companies
in the Global Medical Care industry.

( Industry Median: 19.36 vs. AMSG: 10.94 )
Ranked among companies with meaningful EV-to-EBIT only.
AMSG' s EV-to-EBIT Range Over the Past 10 Years
Min: 3.5  Med: 7.20 Max: 15.7
Current: 10.94
3.5
15.7
EV-to-EBITDA 9.41
AMSG's EV-to-EBITDA is ranked higher than
75% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 13.84 vs. AMSG: 9.41 )
Ranked among companies with meaningful EV-to-EBITDA only.
AMSG' s EV-to-EBITDA Range Over the Past 10 Years
Min: 3.2  Med: 6.50 Max: 13
Current: 9.41
3.2
13
PEG 2.28
AMSG's PEG is ranked higher than
59% of the 82 Companies
in the Global Medical Care industry.

( Industry Median: 2.70 vs. AMSG: 2.28 )
Ranked among companies with meaningful PEG only.
AMSG' s PEG Range Over the Past 10 Years
Min: 0.32  Med: 1.17 Max: 15.54
Current: 2.28
0.32
15.54
Shiller P/E 39.45
AMSG's Shiller P/E is ranked lower than
69% of the 45 Companies
in the Global Medical Care industry.

( Industry Median: 27.41 vs. AMSG: 39.45 )
Ranked among companies with meaningful Shiller P/E only.
AMSG' s Shiller P/E Range Over the Past 10 Years
Min: 12.47  Med: 20.57 Max: 48.18
Current: 39.45
12.47
48.18
Current Ratio 1.49
AMSG's Current Ratio is ranked higher than
57% of the 224 Companies
in the Global Medical Care industry.

( Industry Median: 1.35 vs. AMSG: 1.49 )
Ranked among companies with meaningful Current Ratio only.
AMSG' s Current Ratio Range Over the Past 10 Years
Min: 1.37  Med: 3.23 Max: 4.94
Current: 1.49
1.37
4.94
Quick Ratio 1.43
AMSG's Quick Ratio is ranked higher than
59% of the 224 Companies
in the Global Medical Care industry.

( Industry Median: 1.23 vs. AMSG: 1.43 )
Ranked among companies with meaningful Quick Ratio only.
AMSG' s Quick Ratio Range Over the Past 10 Years
Min: 1.32  Med: 3.02 Max: 4.62
Current: 1.43
1.32
4.62
Days Inventory 40.77
AMSG's Days Inventory is ranked lower than
73% of the 164 Companies
in the Global Medical Care industry.

( Industry Median: 18.31 vs. AMSG: 40.77 )
Ranked among companies with meaningful Days Inventory only.
AMSG' s Days Inventory Range Over the Past 10 Years
Min: 10.86  Med: 12.24 Max: 42.64
Current: 40.77
10.86
42.64
Days Sales Outstanding 47.34
AMSG's Days Sales Outstanding is ranked lower than
54% of the 202 Companies
in the Global Medical Care industry.

( Industry Median: 43.55 vs. AMSG: 47.34 )
Ranked among companies with meaningful Days Sales Outstanding only.
AMSG' s Days Sales Outstanding Range Over the Past 10 Years
Min: 34.74  Med: 39.58 Max: 52.45
Current: 47.34
34.74
52.45
Days Payable 51.12
AMSG's Days Payable is ranked higher than
55% of the 152 Companies
in the Global Medical Care industry.

( Industry Median: 37.56 vs. AMSG: 51.12 )
Ranked among companies with meaningful Days Payable only.
AMSG' s Days Payable Range Over the Past 10 Years
Min: 18.16  Med: 21.18 Max: 65.73
Current: 51.12
18.16
65.73

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 0.62
AMSG's Price/Projected FCF is ranked higher than
90% of the 91 Companies
in the Global Medical Care industry.

( Industry Median: 1.73 vs. AMSG: 0.62 )
Ranked among companies with meaningful Price/Projected FCF only.
AMSG' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.25  Med: 0.60 Max: 3.07
Current: 0.62
0.25
3.07
Price/DCF (Earnings Based) 2.10
AMSG's Price/DCF (Earnings Based) is ranked lower than
79% of the 29 Companies
in the Global Medical Care industry.

( Industry Median: 1.73 vs. AMSG: 2.10 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.06
AMSG's Price/Median PS Value is ranked higher than
52% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 1.04 vs. AMSG: 1.06 )
Ranked among companies with meaningful Price/Median PS Value only.
AMSG' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.5  Med: 1.05 Max: 2.12
Current: 1.06
0.5
2.12
Price/Peter Lynch Fair Value 1.98
AMSG's Price/Peter Lynch Fair Value is ranked higher than
61% of the 46 Companies
in the Global Medical Care industry.

( Industry Median: 2.20 vs. AMSG: 1.98 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
AMSG' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.4  Med: 1.18 Max: 4.93
Current: 1.98
0.4
4.93
Earnings Yield (Greenblatt) (%) 9.10
AMSG's Earnings Yield (Greenblatt) (%) is ranked higher than
90% of the 223 Companies
in the Global Medical Care industry.

( Industry Median: 4.10 vs. AMSG: 9.10 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
AMSG' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 6.4  Med: 13.90 Max: 28.5
Current: 9.1
6.4
28.5
Forward Rate of Return (Yacktman) (%) 24.05
AMSG's Forward Rate of Return (Yacktman) (%) is ranked higher than
85% of the 103 Companies
in the Global Medical Care industry.

( Industry Median: 10.71 vs. AMSG: 24.05 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
AMSG' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 3.7  Med: 25.90 Max: 58.7
Current: 24.05
3.7
58.7

More Statistics

Revenue (TTM) (Mil) $2,721
EPS (TTM) $ 3.03
Beta0.60
Short Percentage of Float9.00%
52-Week Range $54.11 - 87.42
Shares Outstanding (Mil)54.80

Analyst Estimate

Dec16 Dec17
Revenue (Mil $)
EPS ($) 4.34 4.86
EPS without NRI ($) 4.34 4.86
EPS Growth Rate
(3Y to 5Y Estimate)
N/A
» More Articles for NAS:AMSG

Headlines

Articles On GuruFocus.com
Howard Marks' Largest Trades in Second Quarter Sep 29 2015 
Howard Marks Buys 13 New Stocks in Q3 Nov 14 2014 
Weekly CFO Sells Highlight: V, SCLN, VR, AMSG Jun 25 2012 
AmSurg Corp: Free Cash Flow not what it seems (AMSG) Aug 04 2011 
Amsurg Corp. (AMSG) Executive VP & CFO Claire M Gulmi sells 30,000 Shares Mar 17 2011 
Amsurg Corp. (AMSG) Executive VP & CFO Claire M Gulmi sells 27,500 Shares Nov 12 2010 
Amsurg Corp. Reports Operating Results (10-Q) Nov 05 2010 
Amsurg Corp. Reports Operating Results (10-Q) May 09 2009 

More From Other Websites
AMSURG CORP Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to... May 27 2016
AmSurg Declares Quarterly Preferred Stock Dividend May 26 2016
AmSurg Declares Quarterly Preferred Stock Dividend May 26 2016
AmSurg (AMSG): Strong Q1 on Organic & Acquisition Growth May 26 2016
AmSurg’s Physician Services Division – Sheridan – Acquires Jandee Anesthesiology Partners,... May 24 2016
AmSurg’s Physician Services Division – Sheridan – Acquires Jandee Anesthesiology Partners,... May 24 2016
AmSurg Looks Vulnerable on the Charts May 23 2016
AMSURG CORP Financials May 14 2016
AmSurg Corp. breached its 50 day moving average in a Bearish Manner : AMSG-US : May 13, 2016 May 13 2016
AMSURG CORP Files SEC form 10-Q, Quarterly Report May 06 2016
AmSurg (AMSG) Q1 Earnings in Line, EPS Outlook Raised May 06 2016
AmSurg Corp. :AMSG-US: Earnings Analysis: Q1, 2016 By the Numbers May 05 2016
Edited Transcript of AMSG earnings conference call or presentation 3-May-16 9:00pm GMT May 04 2016
Amsurg tops Street 1Q forecasts May 03 2016
Amsurg tops Street 1Q forecasts May 03 2016
AmSurg Corp Earnings Call scheduled for 5:00 pm ET today May 03 2016
AmSurg Announces 27% Growth in First-Quarter Net Revenues, with Strong Same-Center and Same-Contract... May 03 2016
AMSURG CORP Files SEC form 8-K, Results of Operations and Financial Condition May 03 2016
AmSurg Announces 27% Growth in First-Quarter Net Revenues, with Strong Same-Center and Same-Contract... May 03 2016
Q1 2016 AmSurg Corp Earnings Release - After Market Close May 03 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)